XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award  
Transactions under the Company's stock option plans

    

    

    

Weighted

    

Weighted 

average

average 

remaining

Aggregate

exercise

contractual 

intrinsic

Shares

price

life in years

value

Outstanding at December 31, 2021

 

688,533

$

17.56

 

6.6

$

5,986,666

Options granted

 

 

 

 

Options exercised

 

(47,374)

 

13.49

 

 

Options forfeited

 

(9,164)

 

19.62

 

 

Options expired

 

 

 

 

Outstanding at March 31, 2022

 

631,995

$

17.83

 

6.5

$

6,414,948

Exercisable at March 31, 2022

502,179

$

17.36

 

6.0

$

5,335,232

Schedule of fair values of the options granted

The fair values of the options granted during the three months ended March 31, 2021 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions. There were no options granted during the three months ended March 31, 2022:

For the three months ended March 31, 

2022

    

2021

Number of options granted

 

89,000

Weighted average exercise price

$

$

19.21

Weighted average fair value of options

$

$

7.72

Expected life in years (1)

 

 

8.38

Expected volatility (2)

 

%  

 

43.69

%

Risk-free interest rate (3)

 

%  

 

1.14

%

Dividend yield (4)

 

%  

 

1.68

%

(1)The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding.
(2)The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options.
(3)The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant.
(4)The expected dividend yield is the projected annual yield based on the grant date stock price.
Schedule of Information About Options Exercised

Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during the three months ended March 31, 2022 and 2021:

For the three months ended March 31, 

    

2022

    

2021

Number of options exercised

 

47,374

 

12,467

Total intrinsic value of options exercised

$

746,292

$

170,023

Cash received from options exercised

$

639,214

$

80,113

Tax deduction realized from options

$

224,522

$

51,151

Schedule of Stock Options, by Exercise Price Range

The following table summarizes information about stock options outstanding and exercisable at March 31, 2022:

Options outstanding

Options exercisable

    

Weighted average 

    

Weighted 

    

    

Weighted

Options

remaining contractual 

average 

Options

average

Range of exercise prices

outstanding

life (in years)

exercise price

exercisable

exercise price

$6.01 - $12.00

 

108,261

 

3.3

$

9.06

 

108,261

$

9.06

$12.01 - $18.00

 

123,933

 

7.0

 

16.48

 

85,607

 

16.17

$18.01 - $24.00

 

399,801

 

7.3

 

20.62

 

308,311

 

20.60

Total

 

631,995

 

6.5

$

17.83

 

502,179

$

17.36

Summary of Nonvested Restricted Stock Activity

    

    

Average grant

Shares

date fair value

Nonvested restricted stock at December 31, 2021

 

119,487

$

21.00

Granted

 

70,000

 

27.52

Cancelled

 

(8,025)

 

22.89

Vested

 

(26,092)

 

19.72

Nonvested restricted stock at March 31, 2022

 

155,370

$

24.06

Restricted Stock Grants

Restricted stock awards granted during the three months ended March 31, 2022 and 2021 were as follows:

For the three months ended March 31, 

    

2022

    

2021

Number of shares granted

 

70,000

 

30,000

Average grant date fair value

$

27.52

$

19.46

Summary of Components of Net Periodic Pension Cost of Defined Benefit Plan Recognized

For the three months ended March 31, 

(In thousands)

    

2022

    

2021

Service cost (1)

$

37

$

(34)

Interest cost

 

47

 

34

Amortization of prior service cost (2)

 

 

21

Net periodic benefit cost

$

84

$

21

(1)Reduction in service in 2021 cost totaling $137 thousand to be recognized over one year due to the recalculation of the President and CEO’s salary projection.
Summary Of Changes In Benefit Obligations Of Defined Benefit Plan

The following table summarizes the changes in benefit obligations of the defined benefit plan during the three months ended March 31, 2022 and 2021:

For the three months ended March 31, 

(In thousands)

    

2022

    

2021

Benefit obligation, beginning of year

$

4,521

$

3,845

Service cost (1)

 

37

 

(34)

Interest cost

 

47

 

34

Benefit obligation, end of period

$

4,605

$

3,845

(1)Reduction in service cost totaling $137 thousand to be recognized over one year due to the recalculation of the President and CEO’s salary projection.
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs Compensation expense related to stock options and the related income tax benefit for the three months ended March 31, 2022 and 2021 are detailed in the following table:

For the three months ended March 31, 

    

2022

    

2021

Compensation expense

$

163,327

$

207,602

Income tax benefit

$

47,201

$

59,997

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs

Compensation expense related to restricted stock for the three months ended March 31, 2022 and 2021 is detailed in the following table:

For the three months ended March 31, 

    

2022

    

2021

Compensation expense

$

231,003

$

166,349

Income tax benefit

$

66,760

$

48,075